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Background 45 
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Neutrophil gelatinase-associated lipocalin (NGAL) is an early 46 indicator of acute kidney injury (AKI) in dogs and its use has 47 not been evaluated in dogs with sepsis. 48 
Animals:  49 Fifteen dogs with sepsis requiring laparotomy (study dogs) and 50 10 dogs undergoing surgery for intervertebral disc disease 51 (control dogs).  52 
Objective:  53 To determine whether NGAL increases in dogs with 54 sepsis undergoing emergency laparotomy and whether it is 55 correlated with development of AKI and survival.  56 
Methods: 57 Longitudinal study conducted at a referral teaching hospital. 58 Serum (sNGAL), urinary NGAL normalized to creatinine (UNCR) 59 and serum creatinine concentration were measured at 4 time 60 points (admission, after anesthesia, and 24 and 48 hours post-61 surgery). Development of AKI (increase in serum creatinine 62 concentration of 0.3 mg/dL) and in–hospital mortality were 63 recorded.  64 Linear mixed-model analysis was employed to assess 65 differences between groups over time. Mann-Whitney U test 66 was performed for comparison of continuous variables 67 
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between groups and Chi square or Fisher’s exact tests were 68 used to assess correlation between discrete data.  69 
Results 70 Serum NGAL and UNCR were significantly higher in study dogs 71 across all time points (p= 0.007 and p < 0.001 respectively) 72 compared with controls. UNCR in the study group was not 73 significantly different between survivors (n=12) and non-74 survivors (n=3). Dogs that received hydroxyethyl starch had 75 significantly higher UNCR across all time points (p= 0.04) than 76 those that did not.  77 
Discussion – Conclusion 78 sNGAL and UNCR are increased in dogs with sepsis requiring 79 emergency laparotomy. Additional studies are needed to 80 evaluate its role as a marker of AKI in this population.  81 
 82 
Introduction  83  84 Acute kidney injury is defined as sudden injury to the renal 85 parenchyma and reduction in renal function, regardless of 86 underlying cause1. In critical illness and in sepsis, AKI has been 87 identified as one of the main contributors to morbidity and 88 mortality in human patients.2,3 89 
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The incidence of AKI in hospitalized septic dogs managed in an 90 intensive care setting has been reported as 12% and the in-91 hospital mortality rate for dogs with AKI varies from 54% to 92 86%.4,5 93 No consensus has yet been reached in veterinary medicine 94 however with regard to criteria that should be used to define 95 kidney injury. There are several emerging classification 96 systems available, including Veterinary Acute Kidney Injury 97 staging system (VAKI) and Risk, Injury, Failure, Loss of kidney 98 function and End-stage kidney disease (RIFLE)-like criteria.4,6  99 The main pitfalls of the current systems are the use of 100 insensitive and poorly specific markers, such as serum 101 creatinine concentration or urine output. Serum creatinine 102 concentration is not linearly related to GFR and can be 103 influenced by factors other than renal function such as 104 muscular mass and hydration state.7 Glomerular filtration rate 105 (GFR) is the gold standard for diagnosis of renal disease but 106 this method, apart from not being readily clinically available, 107 only detects reduction in renal function and not cellular injury, 108 thus, leading to delayed recognition of disease.1,8  109 Since the 1990’s, there has been a perceived need to identify 110 early markers of AKI in order to identify at-risk patients. To 111 this end, many biomarkers, such as N-acetyl-β-d-112 
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glucosaminidase (NAG), kidney injury molecule-1 (KIM-1) and 113 neutrophil gelatinase-associated lipocalin (NGAL) have been 114 studied in human and canine patients. 7,8 115 Neutrophil gelatinase-associated lipocalin is a 25 kDa protein, 116 belonging to the lipocalin family. It is covalently bound to 117 gelatinase and secreted by neutrophils and normally is 118 expressed at low concentrations in the kidney, lung, trachea 119 and gastrointestinal tract.9,10  It is freely filtered through the 120 glomerulus and re-absorbed in the proximal tubule, such that 121 healthy individuals usually have very low urinary excretion of 122 NGAL.11 Its production is highly upregulated when epithelial 123 cell damage occurs. In clinical studies in people and dogs, its 124 concentration in urine increases 24 to 72 hours before serum 125 creatinine concentration, which enables earlier detection of 126 AKI. 9,12,13 Neutrophil gelatinase-associated lipocalin can be 127 measured in plasma, serum or in urine and it usually is 128 expressed as an absolute concentration. In some studies, 129 urinary NGAL has been normalized to urinary creatinine 130 concentration in an attempt to decrease variation associated 131 with changes in urine volume. 12,14,15   132 Plasma and urine NGAL is increased in people with sepsis and 133 studies have shown an inconsistent ability for plasma or serum 134 
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NGAL to detect AKI in humans with severe sepsis or septic 135 shock. 16-17  136 The ability of urinary NGAL to predict AKI recently has been 137 evaluated in veterinary medicine. A number of clinical 138 studies,  published in the last few years, have shown a 139 significantly higher urinary NGAL concentration in dogs with 140 AKI compared to healthy dogs. 12-14 141 The aim of the present study was to evaluate the usefulness of 142 both serum NGAL and urine NGAL normalized to urinary 143 creatinine (UNCR) for detecting AKI in dogs with sepsis 144 undergoing emergency laparotomy compared to dogs with 145 intervertebral disc disease undergoing surgery. It was 146 hypothesized that an increase in urinary NGAL concentration 147 would be associated with development of AKI, longer time to 148 discharge, increased morbidity (assessed by the Acute Patient 149 Physiologic and Laboratory evaluation score [APPLE] full 150 scoring system and Multiple organ dysfunction syndrome 151 [MODS] criteria) and higher mortality.  152  153 
Material and Methods 154 The study was a prospective investigation performed on client-155 owned dogs. The protocol was approved by the Ethics and 156 Welfare Committee of the Royal Veterinary College, London 157 
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(URN 2012 1155) and informed owner consent was obtained 158 before enrolling each dog in the study.  159 The study group included dogs with sepsis that were to 160 undergo emergency laparotomy. Dogs initially were recruited if 161 they fulfilled Systemic inflammatory response syndrome (SIRS) 162 criteria (Table 1).18 Dogs were included in the analysis if they 163 fulfilled criteria for sepsis (i.e. presence of SIRS and confirmed 164 or suspected infection).19 Infection was defined as the presence 165 of intracellular bacteria on cytological examination or 166 microbiological evidence of infection in the abdominal fluid or 167 aspirates from an abscess. Dogs with azotemia (defined as 168 plasma or serum creatinine concentration > 1.57 mg/dl [138 169 µmol/l]) on presentation, or a history of chronic kidney 170 disease, were excluded from the study.  171 A control group of systemically healthy dogs undergoing 172 emergency surgical intervention for intervertebral disk disease 173 (IVDD) also was recruited.  174  175 
Admission data 176 Clinical data was collected on admission and included 177 signalment, disease process, heart rate, respiratory rate, rectal 178 temperature, systolic blood pressure, whole blood lactate 179 concentration and serum creatinine concentration.  180 
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 181 
Hospitalization data 182 Before or during the course of hospitalization, administration 183 of vasopressors, hydroxyethyl starches, blood products, human 184 serum albumin and potentially nephrotoxic drugs (e.g. non 185 steroidal anti-inflammatory drugs [NSAID], angiotensin-186 converting enzyme [ACE]-inhibitors) were recorded. 187 Occurrence of AKI, azotemia, hypotension and survival were 188 recorded as categorical data. Acute kidney injury was defined 189 as an increase in serum creatinine concentration of 0.3 mg/dl 190 (26.4 µmol/l) within 48 hours, in keeping with the Acute 191 kidney injury network (AKIN) criteria.4 Serum creatinine 192 concentration was measured on admission, post-anesthesia 193 and 24 and 48 hours post-surgery. Hypotension was defined as 194 a systolic Doppler pressure <90 mmHg or a mean invasive 195 arterial pressure <60 mmHg. The APPLE full score on 196 admission was calculated for each dog when data were 197 available.20 Multi-organ dysfunction syndrome was defined as 198 
≥2 organ systems having signs of dysfunctions.5  199 
 200 
Sampling and sample processing 201 Blood and urine samples were taken from dogs in both groups 202 for NGAL and creatinine measurements. Samples were taken at 203 
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4 time points: (I) on admission, (II) after anesthesia (within 2 204 hours post-anesthesia), and (III) 24 and (IV) 48 hours post-205 operatively. Because ours was a clinical study performed in the 206 United Kingdom on non-experimental animals, only residual 207 volumes of blood taken from samples for clinical need could be 208 used.  209 Urine samples were collected by voiding or from an indwelling 210 urinary catheter, and an aliquot of each fresh urine sample was 211 submitted to the laboratory for urinalysis (refractometric urine 212 specific gravity, dipstick semi-quantitative chemistry and 213 sediment examination) and urine-protein-to-creatinine ratio 214 (UP:C) measurement.c  Pyuria was defined as ≥5 white blood 215 cells per high power field.21 Aliquots of the urine and serum 216 samples were centrifuged at 400 g for 5 minutes and the 217 supernatant frozen at -70°C within 1 hour (urine) and 8 hours 218 (serum) for later batch analysis.   219 Serum creatinine concentrations were determined from stored 220 frozen serum samples using a biochemical analyzer.c Serum 221 NGAL was measured on the same day using the same thawed 222 samples. All samples thawed for NGAL analysis were re-frozen 223 within 1 hour to allow for re-analysis if required.  224 Urine and serum NGAL concentrations were determined using 225 a sandwich ELISAa following the manufacturer’s instructionsd. 226 
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Urine and serum samples initially were diluted 1:200 using the 227 diluent provided in the kit and the assay was performed 228 according to the manufacturer’s instructions. When necessary, 229 dilution of the samples was adjusted (1:20 to 1:10000) to 230 ensure that the NGAL concentration fell on the linear part of the 231 standard curve. Samples requiring further dilution were 232 thawed and frozen a maximum of 3 times. This thaw-refreeze 233 process has been shown not to affect NGAL stability.15 Urinary 234 NGAL concentrations were normalized by the urinary 235 creatinine concentration (mg/dl) to express results as UNCR. 236 The final normalized uNGAL is expressed as ng/mg.  237 A dual set of pooled quality control samples (high and low 238 concentrations) also were included within each plate for 239 assessment of inter-assay and intra-assay variability.  240  241 
Statistics 242 Statistical analyses were performed in SPSSe and figures were 243 drawn using Graphpad Prism.f Continuous data was presented 244 as median (range) in the original scale because some of the data 245 have been log transformed in the statistical analysis and the 246 sample size was small.  247 Repeated measurement of UNCR and sNGAL were analyzed in a 248 linear mixed-effects model (LMM) taking time, group (sepsis vs 249 
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control dogs), colloids, AKI, MODS, hypotension and blood 250 product requirement as potential fixed effects and dog as 251 random effect. Potential 2-way interactions between 252 categorical fixed factors and time were assessed. A continuous 253 variable was log transformed if its residuals from LMM analysis 254 were skewed to the right.  255 Although many continuous data were normally distributed, 256 admission data between clinical course and treatment groups 257 and survivors were compared using the Mann Whitney-U test 258 because of the small sample size. Similarly, Spearman’s 259 correlation coefficient was used to measure linear correlation 260 between 2 sets of continuous data to avoid the potential 261 influence of outliers. The association between categorical 262 variables was analyzed using Chi-squared or Fisher’s exact test 263 if the contingency table contained a value <5. Statistical 264 significance was set at p < 0.05. 265 
 266 
Results 267 
Recruitment and admission characteristics 268 Twenty-one dogs were enrolled in the study group and 10 dogs 269 were enrolled in the control group between June 2012 and 270 August 2013. One dog in the study group subsequently was 271 excluded because no urine had been stored for pre-surgery 272 
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NGAL analysis. Twenty dogs initially were included in the 273 study.  Five of these were removed because they did not fulfill 274 criteria for sepsis.  Four of these dogs had gastric dilatation and 275 volvulus and 1 had severe gastroenteritis. The final study group 276 therefore was represented by 15 dogs. Of these dogs, 13 had 277 septic peritonitis and 2 had intra-abdominal abscessation.  278 Admission variables and days of hospitalization were 279 compared between the study and the control groups and 280 reported in Tables 2 and 3.  281 
 282 
Clinical course and treatment 283 All dogs, in both the study and control groups, had blood 284 pressure recorded over the course of the entire anesthetic 285 period, and the study population had periodic blood pressure 286 measurements made during hospitalization (Tables 2 and 3). 287 Eleven of 15 dogs in the study group were hypotensive (4 pre-288 operatively and 10 intra-operatively). Two of 3 non-survivors 289 were hypotensive in the immediate post-operative period and 290 required vasopressor therapy.  Blood pressure was not 291 measured on admission for any of the dogs in the control group 292 because they were considered to be cardiovascularly stable 293 based on clinical examination.  294 
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None of the dogs in the control group developed AKI whereas 295 2/15 (13%) dogs in the study group met AKI criteria but did 296 not become azotemic (serum creatinine concentration 297 increased by 0.57 mg/dl [50 µmol/l] and 0.65 mg/dl [57 298 
µmol/l] in 24 hours). These 2 dogs later were euthanized 299 because of clinical deterioration. No difference was identified 300 between the incidence of AKI in the study and control groups 301 (p= 0.5; Table 3).  302 In the study population, 12 dogs (80%) survived to discharge, 1 303 dog died and 2 were euthanized after clinical deterioration. 304 Nine dogs (90%) in the control group were discharged, with 1 305 being euthanized because of persistent paraplegia (Table 3). 306 
 307 
Serum NGAL results 308 Intra-assay and inter-assay variability for sNGAL was 2.0% and 309 10.4% for the high concentration quality control and 7.7 and 310 19.3% for the low concentration quality control, respectively. 311 No significant difference was identified for time-group 312 interaction and among times, but sNGAL was significantly 313 higher in the study population compared to the control 314 population (p= 0.007; Figure 1 and Table 4). A time-colloid 315 administration interaction was present (p=0.01). The cause of 316 significance seemed to derive mainly from difference between 317 
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time points within the non-colloid group, and there was no 318 difference between colloid group at all time points (Table 4). 319 There was no association between AKI, MODS  development, 320 hypotension and survival and sNGAL (Table 4).   321 
 322 
UNCR results 323 There was no time-group interaction and no difference among 324 times for UNCR, but the study group had significantly higher 325 UNCR than did the control dogs at all measured time points 326 (p<0.001). No association was detected between UNCR and 327 development of AKI (p = 0.25) or MODS (p= 0.49; Figure 2 and 328 Table 4). Four of the 30 dogs (2 in each group) had pyuria. 329 There was no association between UNCR and the presence of 330 pyuria at any of the time points (p=0.55). None of the dogs in 331 the control group was diagnosed with a urinary tract infection 332 (UTI).  One dog in the study group was diagnosed with a UTI, 333 and this dog also had prostatic abscessation and septic 334 peritonitis.  335  336 No time-colloids administration interaction was identified and 337 no difference among time points was detected. Dogs that 338 received hydroxyethyl starchg (12/30) however had 339 significantly higher UNCR compared to dogs that did not across 340 
 16 
all time points (p =0.04; Figure 3 and Table 4), with the 2 dogs 341 that developed AKI receiving colloids, either preoperatively or 342 intra-operatively.  343 All dogs in the control group received NSAIDs after anesthesia, 344 whereas none of the dogs in the study group received NSAIDs 345 after admission. No time-NSAID administration interaction and 346 no difference among times was detected, but dogs in the study 347 group that did not receive NSAIDs before admission (n=11) had 348 significantly higher UNCR (p=0.04; Table 4).  349 There was a significant association between UNCR and days 350 spent in the intensive care unit (ICU; Table 5) but no 351 correlation was found between UNCR and duration of 352 hospitalization (admission, p= 0.5; post-anesthesia, p =0.3; 24 353 hours, p= 0.34; 48 hours, p =0.09). 354 No significant difference in UNCR was detected between dogs 355 that survived to discharge and those that did not (p = 0.08).  356  357 
Correlation  358 There was moderate correlation between UNCR and sNGAL on 359 admission (rs 0.76) and post-anesthesia (rs 0.82; Table 4). No 360 correlation was found between UNCR and urinary pH and urine 361 specific gravity (USG).  362 
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There was a correlation between UNCR and UP:C (admission, rs 363 0.61; post-anesthesia, rs 0.92; 24 hours, rs 0.87; 48 hours, rs 364 0.75) but no correlation was found between UNCR and APPLE 365 full score at any of the time points (Table 4). 366  367 
Discussion 368  369 Our study focused on detecting the effect of sepsis on sNGAL 370 and UNCR and to assess their changes over the course of 371 hospitalization. The control population was chosen to compare 372 the effect of general anesthesia and surgery on NGAL in 373 comparison to septic dogs undergoing emergency laparotomy. 374 This group also was chosen because it theoretically allowed 375 timed and non-invasive urine sampling because of routine 376 placement of urinary catheters or bladder expression.   377 Sepsis has been shown to be associated with development of 378 AKI secondary to ischemia-reperfusion injury, damage induced 379 by pro-inflammatory cytokines and oxidative stress and 380 tubular dysfunction leading to decreased glomerular filtration 381 and tubular reabsorbtion dysregulation.22 Neutrophil 382 gelatinase associated lipocalin is secreted by neutrophils and it 383 is therefore logical to expect an increase in its concentration in 384 inflammatory states. In particular, during sepsis, NGAL 385 
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expression increases, not only in the kidney, but also in 386 leukocytes and liver. Therefore, higher NGAL both in blood and 387 in urine are expected, regardless of AKI.11 A study in human 388 patients showed that sNGAL was increased in patients with 389 sepsis, severe sepsis and septic shock, but was not able to 390 detect AKI in this population, especially in the sicker 391 categories.16 The results of the present study confirm that 392 sNGAL also in increased in dogs with sepsis compared to a 393 control population. However, sNGAL was not associated with 394 mortality or correlated with the severity of the disease, as 395 assessed by the APPLE scoring system or MODS development, 396 suggesting that this marker may not be a useful clinical severity 397 predictor.  398 The UNCR differed between the study and control groups 399 across all time points evaluated (p < 0.001). The median UNCR 400 concentration in the study group post-anesthesia was as high 401 as 114 times (admission) and 185 times higher than in the 402 control group, highlighting the marked difference between the 403 2 groups. However, similar to sNGAL, UNCR was not associated 404 with mortality, suggesting that this marker may not be useful to 405 assess the severity of disease.   406 A study in people showed that septic AKI patients had higher 407 urinary NGAL than non-septic AKI patients.23 Both sNGAL and 408 
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UNCR were not associated with AKI development over the 409 course of hospitalization in this study. This finding may be a 410 consequence of the inability of NGAL to distinguish between 411 the presence of AKI and systemic inflammation in septic dogs, 412 and as a result may suggest that NGAL is a poor marker of AKI 413 in this population of dogs. The lack of significance to detect AKI, 414 however, could have been a result of the small population size 415 and thus indicate a type II error. 416 Neutrophil gelatinase associated lipocalin increases 3 hours 417 after ischemic renal injury in people undergoing cardio-418 pulmonary bypass and peaks at 36 hours in critically ill 419 patients developing AKI during hospitalization.24 However 420 NGAL has been shown to increase up to 72 hours earlier than 421 serum creatinine concentration in the event of AKI. Therefore, 422 this study may not have detected an increase in serum 423 creatinine concentration if it occurred after the 48 hours 424 sample, potentially leading to AKI recognition being missed in 425 some patients.10,23 This time window was selected based on 426 evidence in human patients showing that adverse outcome is 427 associated with increased serum creatinine concentration 428 within 48 hours, and the immediate post-operative period was 429 deemed most appropriate to detect eventual development of 430 AKI.13,25  431 
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The increase in UNCR in dogs with sepsis in our study perhaps 432 represents sub-clinical AKI, not detected by the VAKI system, or 433 may have been related to an increase in serum creatinine 434 concentrations that occurred after 48 hours.4 The increase in 435 serum creatinine concentration used to define AKI in our study 436 was considered to be a sensitive way of identifying these dogs. 437 However, serum creatinine concentration may not be altered in 438 the event of tubular injury, indicated by an increase in NGAL 439 production, because the GFR of the affected nephrons may not 440 be altered or overall renal compensation may occur in other 441 nephrons. Conversely, tubular injury, detected by an increase in 442 NGAL concentration, may lead to a decrease in glomerular 443 function as a consequence of tubular flow obstruction and 444 tubulo-glomerular interaction.26 In this situation, NGAL may not 445 be correlated with GFR, and its increase does not consistently 446 reflect a change in serum creatinine concentration.  447 It is unlikely that the difference in UNCR between the 2 groups 448 was a consequence of altered passage of NGAL across the 449 glomerular filtration barrier. In fact, although there was an 450 association between UP:C and UNCR, sNGAL and UNCR were 451 only moderately correlated on admission and post-anesthesia. 452 It appears more likely that in severe inflammation renal 453 derangements lead to decreased re-absorptive capacity in the 454 
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proximal tubules or up-regulation of NGAL production at the 455 level of the thick ascending loop, distal tubule and collecting 456 ducts.10  457 One study showed that, in dogs undergoing surgery, urinary 458 NGAL was significantly higher in dogs with AKI 12 hours post-459 operatively, whereas plasma NGAL was not able to detect AKI.13 460 Another study in dogs with a variety of diseases, including 461 heatstroke and snake envenomation, showed that UNCR on 462 admission was significantly higher in dogs with AKI (grade I to 463 V) and detected AKI earlier than the increase in plasma 464 creatinine concentration.12 However, 9 of 15 dogs (60%) in our 465 study had UNCR results on admission higher than the cut-off of 466 238 ng/mg established by a previous study for distinguishing 467 non-azotemic AKI grade I patients from dogs with related renal 468 or urinary conditions.12 However, the pathophysiology of AKI in 469 sepsis is substantially different from other causes of AKI, such 470 as ischemia or toxic damage, and NGAL expression is 471 upregulated in inflammatory conditions, such as infection.21,22 472 Of the 9 dogs with UNCR >238 ng/mg, only 2 developed AKI 473 and none of them developed azotemia. This cut-off may 474 therefore not be useful in dogs with sepsis and additional 475 studies are needed to establish a cut-off for this population.  476 Both UNCR and sNGAL were not significantly associated with 477 
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time to discharge but were associated with ICU stay. Timing of 478 discharge and ICU hospitalization are clinician-dependent and 479 financially-based decisions and these factors might have 480 influenced this result. In addition, our control population was 481 represented by patients with IVDD, which have predictably 482 long hospitalization times.  483  484 Patients that did not receive NSAIDs before admission had 485 higher UNCR compared to patients that did across all time 486 points. This difference may have been simply a consequence of 487 more severe disease in dogs not receiving NSAIDs, because 488 there currently is no evidence that NSAIDs may induce urinary 489 NGAL down-regulation.  490 An interesting finding was the significant difference in UNCR 491 between dogs that received colloids and dogs that did not. The 492 higher UNCR in dogs that received colloids was consistent 493 across all 4 time points, and UNCR was increased before 494 surgery although only 4 of the 9 dogs were given colloids on 495 admission, whereas 4 received them intra-operatively and 1 496 post-operatively. This difference may simply reflect a 497 difference in severity of illness, because colloids typically are 498 used more often in dogs with more serious signs of 499 hypoperfusion and potentially more severe inflammation. This 500 
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may have induced an up-regulation of NGAL secretion and an 501 increase in UNCR independent of  colloid administration.11 502 In people, hydroxyethyl starches are associated with  increased 503 risk of kidney injury, and recent studies have highlighted an 504 association between the use of hydroxyethyl starches 505 (including pentastarch and tetrastarch) and kidney injury or 506 renal replacement therapy requirement.27,28 Usually, an 507 increase in uNGAL is expected to occur at least 3 hours after the 508 renal injury.11 If these artificial colloids induced AKI in the dogs 509 of our study, a difference at the pre-anesthesia sample would 510 not be expected, because most patients did not receive 511 hydroxyethyl starches until intra-operatively or post-512 operatively. The results of our study should therefore be 513 interpreted with caution.  514 One limitation of this study is that there were 21/100 urine 515 samples and 40/100 serum samples missing. Analysis of all of 516 the samples may have added further information to our 517 analysis and allowed better interpretation of the data. The 518 absence of results, in addition to the small number of cases 519 enrolled, therefore may have caused the analysis to be 520 underpowered.  521 A second limitation involves the choice of the control group. 522 The median admission data for this group was not significantly 523 
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different from that of the study group, leading to a potential 524 confounding overlap within the population (Tables 1 and 2). 525 However, the underlying diseases affecting the 2 groups were 526 substantially different, being localized in the control dogs and 527 systemic and pro-inflammatory in the study patients. 528 Additional studies may benefit from the use of more stringent 529 SIRS criteria, allowing clear clinical distinction between the 530 control and the study group on admission. 531 In addition, our study monitored serum creatinine 532 concentration for a 48-hours period. Because NGAL may 533 increase up to 72 hours earlier than serum creatinine 534 concentration in the event of renal injury, some patients with 535 AKI may have been missed.11,24.  536 A further limitation includes the clinician-based decision for 537 administration of hydroxyethyl starches, blood products or 538 institution of vasopressor therapy, rendering objective 539 interpretation of these data or assessment of the severity of 540 illness difficult. It also is currently unknown whether drugs, 541 such as human serum albumin, may affect serum and urinary 542 NGAL release and tubular re-absorption, interfering with the 543 results of the study. 544 Additional prospective studies with larger populations of dogs 545 with sepsis and use of additional urinary markers are 546 
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warranted to assess the association between NGAL and 547 inflammation, sepsis and AKI. 548  549  550 Footnotes:  551 a. Dog NGAL ELISA kit, BioPorto Diagnostics, Gentofte, Dk.   552 b. Tecn Sunrise Elisa-reader; Tecan Group, Mannedorf, Ch 553 c. IL600, Instrumentation Laboratory Cheshire, UK 554 d. http://ngal.com/media/44324/kit_043_ifu_ruo.pdf 555 e. SPSS version 20, Chicago, Ill, USA 556 f. Graphpad Prism, version 6, La Jolla, Ca, USA 557 g. Voluven (6% Hydroxyethyl Starch 130/0.4 in 0.9% Sodium 558 Chloride), Fresenius Kabi Norge A.S., Halden Norway 559  560 Bibliography:  561 1. Waikar S.S, Liu K.D, Chertow G.M. Diagnosis, epidemiology and 562 outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008; 3: 563 844-861.  564 2. Uchino S, Kellum J.A, Bellomo R et al. Acute renal failure in 565 critically ill patients: a multinational, multi-center study. JAMA, 566 2005, 294 (7): 813-8.  567 
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Table 1: Systemic Inflammatory Response Syndrome (SIRS) 663 criteria used for inclusion of dogs within the study group. SIRS 664 was defined if patients fulfilled 2 or more criteria.18  665 
 666 
Table 2: Measurements taken at admission and hospitalization 667 time between study and control patients. Measurements are 668 expressed as median (range) and statistical significance was set 669 at P<0.05. NA= not applicable; R.I.: Reference Interval. 670 
 671 
 Table 3: Pre-admission treatment, clinical course and 672 treatment received in the study and in the control dogs. 673 Significant differences are highlighted (significance set at a p 674 
value ≤ 0.05).  675 APPLE score was calculated.20  676 MODS (Multi-Organ Dysfunction Syndrome) was defined as 677 dysfunction of at least two organs.5  678 AKI (Acute Kidney Injury) was defined as an increase of 0.3 679 mg/dl (26.5 µmol/l) from baseline.4  680  681 
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Table 4: Differences in the normalized sNGAL and UNCR for 682 each single category and differences between time and time-683 category interaction. Significant difference was set at p< 0.05. 684 AKI: acute kidney injury; NSAID: non steroidal anti-685 inflammatory drug; MODS: Multi-organ dysfunction syndrome. 686  687 
Table 5: Spearman’s correlation (rs) between UNCR and UP:C, 688 serum creatinine, sNGAL, day in I.C.U and APPLE score. 689 Statistical significance was set at p < 0.05.  690  691  692 
 693 
Figure 1: The medians and interquartile range of serum NGAL 694 at different times between the control and the study group are 695 represented by the bar and the whiskers with all the patients 696 displayed in a scattered plot manner. The two AKI patients are 697 represented by x and  on the graph. sNGAL concentrations 698 were significantly higher across all time points in the study 699 group.  700 
 701 
Figure 2: The medians and interquartile ranges of urinary 702 NGAL to creatinine ratio (UNCR) at different times between the 703 control and the study group are expressed by the bar and the 704 
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whiskers respectively with the single patients displayed in a 705 scatter plot manner. The two patients with AKI have been 706 identified with x and . The study group had significantly 707 higher UNCR across all the time points (p < 0.001).  708 
 709 
Figure 3: The medians and interquartile ranges of urinary 710 NGAL to creatinine ratio (UNCR) at different times between 711 patients that received colloids and patients that did not are 712 expressed by the bar and the whiskers respectively with the 713 single patients displayed in a scatter plot manner. Statistical 714 significance was set at P<0.05. Dogs that received colloids had 715 significantly higher UNCR concentration across all time points.  716 
Variable SIRS criteria fulfilled if Heart rate >120/min Respiratory rate >20/min Body temperature <38.1°C or >39.2°C White blood cell count <6x103 or >16x103 /µl Increased band neutrophils with normal neutrophil count 3%  717 
Table 1: Systemic Inflammatory Response Syndrome (SIRS) criteria used for inclusion of 718 dogs within the study group; SIRS was defined if patients fulfilled 2 or more criteria.18  719  720 
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 721  Study Control p value Heart rate (bpm) 128 (70-190) 120 (80-172) 1 
Respiratory rate (rpm) 36 (20-100) 40 (20-80)  0.69 
Temperature (°C) 39.2 (37.8-40.7) 38.8 (36.9-39.4)  0.36 
White Blood cells (109) 17.3 (2.2-47.8) - - Lactate (mg/dl)  (R.I. 0-22.5) 11.7 (6.3-99) (n=15) 16.2 (16.2-18) (n=3) 0.2 Doppler systolic blood pressure (mmHg) 130 (60-170) - -  722 
Table 2: Measurements taken at admission between study and control patients. 723 Measurements are expressed as median (range) and statistical significance was set at 724 P<0.05. NA= not applicable; R.I.: Reference Interval. 725  726  727  728   729 
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 Study Control P Value 
Admission characteristic Previous surgery (5 days) 5/15 (33%) 0/10 (0%) 0.61 Fluid therapy prior admission (crystalloids)  13/15 (86%) 1/10 (10%) < 0.01 Non steroidal anti-inflammatory medications  4/15 (27%) 6/10 (60%) 0.12 
Clinical Course 
Hypotension  11/15 (73%) 0/10 (0%)  < 0.01 
APPLE score  28 (8-38) (14/15) . . 
MODS  4/15 (27%) 0/10 (0%)   0.12 AKI  2/15 (13%) 0/10 (0%)  0.5 Survival to discharge 12/15 (80%) 9/10 (90%)  0.62 
Treatment  Blood products 5/15 (33%) 0/10 (0%) 0.06 Human serum albumin 3/15 (20%) 0/10 (0%) 0.25 Hydroxyethyl starch (Voluven ®) 9/15 (60%) 0/10 (0%) <0.01 
 35 
Days Hospitalization 7(1-11) 12.5 (1-11)  0.42 
      Days ICU  3 (1-11)  0 (0-0) < 0.01  730 
Table 3: Pre-admission treatment, clinical course and treatment received in the study and 731 in the control dogs. Significant differences are highlighted (significance set at a p value ≤ 732 0.05).  733 APPLE score was calculated.20  734 MODS (Multi-Organ Dysfunction Syndrome) was defined as dysfunction of at least two 735 organs.5 736 AKI (Acute Kidney Injury) was defined as an increase of 0.3 mg/dl (26.5 µmol/l) from 737 baseline.4  738  739  Category Category Time  Time-category interaction sNGAL Sepsis p= 0.007  p= 0.13 p = 0.95  AKI  p= 0.28 p= 0.24 p= 0.83  Hypotension P= 0.49 p= 0.23 p= 0.33  Survival p= 0.09 p= 0.25 p= 0.34  NSAIDs p= 0.12 p= 0.23 p= 0.47  Colloids p=0.72 p= 0.16 p= 0.01  MODS p= 0.49 p= 0.24 p= 0.57  Blood products p= 0.96 p= 0.24 p= 0.43 UNCR Sepsis p< 0.001 p= 0.29 p= 0.12  AKI p= 0.25 p= 0.1 p= 0.5  Hypotension p= 0.55 p= 0.08 p= 0.75  Survival p= 0.08 p= 0.11 p= 0.19  NSAIDs p= 0.04 p= 0.08 p= 0.21  Colloids p= 0.04 p= 0.12 p= 0.07  MODS p= 0.49 p= 0.08 p= 0.44  Blood products p= 0.21 p= 0.1 p= 0.07 
Table 4: Differences in sNGAL and UNCR for each single category and differences between 740 time and time-category interaction. Significant difference was set at p< 0.05. AKI: acute 741 
 36 
kidney injury; NSAID: non steroidal anti-inflammatory drug; MODS: Multi-organ 742 dysfunction syndrome. 743  744   745 
 37 
 746    
UP:C  Serum Creatinine sNGAL  DAYS I.C.U. APPLE score 
UNCR admission 
UP:Cadm 
p < 0.001; rs  
0.61 
Creatadme 
p = 0.17 
sNGALadm 
p < 0.01; rs  
0.76 
p< 0.001; rs 
0.7 
 
p= 0.44 
UNCR post 
UP:Cpost 
p < 0.001; 
rs  0.92 
Creat.post 
 
p=0.03; rs 0.54 
sNGAL.post 
p < 0.01; 
rs  0.82 
p< 0.001; rs 
0.77 
 
p= 0.71 
UNCR 24 UP:C24 p < 0.001; rs  
0.87 
Creat.24 
p = 0.11 
sNGAL24 
p= 0.07 
p< 0.001; rs 
0.79 p= 0.08 
UNCR 48 UP:C48 p= 0.001; rs  
0.75 
Creat.48 
p = 0.15 
sNGAL.48 
p  = 0.33 
p< 0.001; rs 
0.77 p = 0.2 
 747 
Table 5:  748 Spearman’s correlation (rs) between UNCR and UP:C, serum creatinine, sNGAL, day in I.C.U 749 and APPLE score. Statistical significance was set at p < 0.05.  750   751 
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 752  753 
 754    755 
 756 
Figure 1: The medians and interquartile ranges of serum NGAL at different times between 757 the control and the study group are represented by the bar and the whiskers with all the 758 patients displayed in a scattered plot manner. The two AKI patients are represented by x 759 and ♦ on the graph. Serum NGAL concentrations were significantly higher across all time 760 points in the study group. 761  762  763  764 
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   765 
Figure 2: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) 766 at different times between the control and the study group are expressed by the bar and the 767 whiskers respectively with the single patients displayed in a scatter plot manner. The two 768 patients with AKI have been identified with x and ♦. The study group had significantly 769 higher UNCR across all the time points (p < 0.001). Statistical significance was set at p<0.05.  770  771  772  773 
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 775 
Figure 3: The medians and interquartile ranges of urinary NGAL to creatinine ratio (UNCR) 776 at different times between patients that received colloids and patients that did not are 777 expressed by the bar and the whiskers respectively with the single patients displayed in a 778 scatter plot manner. Statistical significance was set at P<0.05. Dogs that received colloids 779 had significantly higher UNCR concentration across all time points.  780 781 
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